On June 2, supporters across the U.S. will recognize the legacy of legendary baseball player Lou Gehrig and his impact on ALS ...

Columnist Kristin Neva, while enjoying an unusually busy weekend, reflects on how finding balance is crucial in her life as an ALS caregiver.

Genetic mutations in many forms of ALS lead to early problems with the transport and function of mitochondria, a study found.

The ALS Network is supporting research using electronic health records to identify existing drugs for repurposing to slow ALS ...

ATH-1105, an experimental oral therapy for ALS, was found to be safe and well tolerated in healthy adult volunteers in a ...

Massachusetts General Hospital's 2025 MGH ALS Young Investigator Awards went to three scholars doing ALS research.

MaaT033, an experimental oral therapy that uses bacteria to restore balance in the gut, may slow ALS progression, a study ...

Patients given Neuronata-R who progressed more slowly saw significant gains in CAFS, slower declines in ALSFRS-R scores, and ...

The FDA has cleared Brainstorm to initiate a Phase 3b clinical trial testing NurOwn (debamestrocel) in people with moderate ALS.

What does coping mean in life? Columnist Kristin Neva mulls it over after she and her husband with ALS take a mental health survey.

ALS Awareness Month amplifies difficult emotions for columnist. It's one of the reasons why sharing is important.